TY - JOUR
T1 - Clinical and Patient-reported Outcome Measures in Men Referred for Consideration of Surgery to Treat Lower Urinary Tract Symptoms
T2 - Baseline Results and Diagnostic Findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)
AU - Lewis, Amanda L.
AU - Young, Grace J.
AU - Abrams, Paul
AU - Blair, Peter S.
AU - Chapple, Christopher
AU - Glazener, Cathryn M.A.
AU - Horwood, Jeremy
AU - McGrath, John S.
AU - Noble, Sian
AU - Taylor, Gordon T.
AU - Ito, Hiroki
AU - Belal, Mohammed
AU - Davies, Melissa C.
AU - Dickinson, Andrew J.
AU - Foley, Charlotte L.
AU - Foley, Steve
AU - Fulford, Simon
AU - Gammal, Mohsen M.
AU - Garthwaite, Mary
AU - Harris, Mark R.E.
AU - Ilie, Petre C.
AU - Jones, Robert
AU - Sabbagh, Samer
AU - Mason, Robert G.
AU - McLarty, Ester
AU - Mishra, Vibhash
AU - Mom, Jaswant
AU - Morley, Roland
AU - Natale, Salvatore
AU - Nitkunan, Tharani
AU - Page, Tobias
AU - Payne, David
AU - Rashid, Tina G.
AU - Saeb-Parsy, Kasra
AU - Sandhu, Sarb S.
AU - Simoes, Adrian
AU - Singh, Gurpreet
AU - Sullivan, Mark
AU - Tempest, Heidi V.
AU - Viswanath, Srinivasa
AU - Walker, Roger M.H.
AU - Lane, J. Athene
AU - Drake, Marcus J.
PY - 2019/5
Y1 - 2019/5
N2 - Background: Clinical evaluation of male lower urinary tract symptoms (MLUTS) in secondary care uses a range of assessments. It is unknown how MLUTS evaluation influences outcome of therapy recommendations and choice, notably urodynamics (UDS; filling cystometry and pressure flow studies). Objective: To report participants’ sociodemographic and clinical characteristics, and initial diagnostic findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM). UPSTREAM is a randomised controlled trial evaluating whether symptoms are noninferior and surgery rates are lower if UDS is included. Design, setting, and participants: A total of 820 men (≥18 yr of age) seeking treatment for bothersome LUTS were recruited from 26 National Health Service hospital urology departments. Intervention: Care pathway based on routine, noninvasive tests (control) or routine care plus UDS (intervention arm). Outcome measurements and statistical analysis: The primary outcome is International Prostate Symptom Score (IPSS) and the key secondary outcome is surgery rates 18 mo after randomisation. International Consultation on Incontinence Questionnaires were captured for MLUTS, sexual function, and UDS satisfaction. Baseline clinical and patient-reported outcome measures (PROMs), and UDS findings were informally compared between arms. Trends across age groups for urinary and sexual PROMs were evaluated with a Cuzick's test, and questionnaire items were compared using Pearson's correlation coefficient. Results and limitations: Storage LUTS, notably nocturia, and impaired sexual function are prominent in men being assessed for surgery. Sociodemographic and clinical evaluations were similar between arms. Overall mean IPSS and quality of life scores were 18.94 and 4.13, respectively. Trends were found across age groups, with older men suffering from higher rates of incontinence, nocturia, and erectile dysfunction, and younger men suffering from increased daytime frequency and voiding symptoms. Men undergoing UDS testing expressed high satisfaction with the procedure. Conclusions: Men being considered for surgery have additional clinical features that may affect treatment decision making and outcomes, notably storage LUTS and impaired sexual function. Patient summary: We describe initial assessment findings from a large clinical study of the treatment pathway for men suffering with bothersome urinary symptoms who were referred to hospital for further treatment, potentially including surgery. We report the patient characteristics and diagnostic test results, including symptom questionnaires, bladder diaries, flow rate tests, and urodynamics. Men being considered for surgery have additional clinical features that may affect treatment decision making and outcomes, notably storage lower urinary tract symptoms and impaired sexual function. Sociodemographic and clinical evaluations were similar between arms. The overall mean International Prostate Symptom Score and quality of life score were 18.94 and 4.13, respectively. Men undergoing urodynamic evaluation expressed high satisfaction with the procedure.
AB - Background: Clinical evaluation of male lower urinary tract symptoms (MLUTS) in secondary care uses a range of assessments. It is unknown how MLUTS evaluation influences outcome of therapy recommendations and choice, notably urodynamics (UDS; filling cystometry and pressure flow studies). Objective: To report participants’ sociodemographic and clinical characteristics, and initial diagnostic findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM). UPSTREAM is a randomised controlled trial evaluating whether symptoms are noninferior and surgery rates are lower if UDS is included. Design, setting, and participants: A total of 820 men (≥18 yr of age) seeking treatment for bothersome LUTS were recruited from 26 National Health Service hospital urology departments. Intervention: Care pathway based on routine, noninvasive tests (control) or routine care plus UDS (intervention arm). Outcome measurements and statistical analysis: The primary outcome is International Prostate Symptom Score (IPSS) and the key secondary outcome is surgery rates 18 mo after randomisation. International Consultation on Incontinence Questionnaires were captured for MLUTS, sexual function, and UDS satisfaction. Baseline clinical and patient-reported outcome measures (PROMs), and UDS findings were informally compared between arms. Trends across age groups for urinary and sexual PROMs were evaluated with a Cuzick's test, and questionnaire items were compared using Pearson's correlation coefficient. Results and limitations: Storage LUTS, notably nocturia, and impaired sexual function are prominent in men being assessed for surgery. Sociodemographic and clinical evaluations were similar between arms. Overall mean IPSS and quality of life scores were 18.94 and 4.13, respectively. Trends were found across age groups, with older men suffering from higher rates of incontinence, nocturia, and erectile dysfunction, and younger men suffering from increased daytime frequency and voiding symptoms. Men undergoing UDS testing expressed high satisfaction with the procedure. Conclusions: Men being considered for surgery have additional clinical features that may affect treatment decision making and outcomes, notably storage LUTS and impaired sexual function. Patient summary: We describe initial assessment findings from a large clinical study of the treatment pathway for men suffering with bothersome urinary symptoms who were referred to hospital for further treatment, potentially including surgery. We report the patient characteristics and diagnostic test results, including symptom questionnaires, bladder diaries, flow rate tests, and urodynamics. Men being considered for surgery have additional clinical features that may affect treatment decision making and outcomes, notably storage lower urinary tract symptoms and impaired sexual function. Sociodemographic and clinical evaluations were similar between arms. The overall mean International Prostate Symptom Score and quality of life score were 18.94 and 4.13, respectively. Men undergoing urodynamic evaluation expressed high satisfaction with the procedure.
KW - Benign prostatic obstruction
KW - Bladder outlet obstruction
KW - Detrusor overactivity
KW - Detrusor underactivity
KW - Lower urinary tract symptoms
KW - Patient-reported outcome measures
KW - Prostate
KW - Surgery
KW - Underactive bladder
KW - Urodynamics
KW - STORAGE
KW - LASER
KW - PREVALENCE
KW - HYPERPLASIA
KW - PHOTOSELECTIVE VAPORIZATION
KW - QUALITY-OF-LIFE
KW - TRANSURETHRAL RESECTION
UR - http://www.scopus.com/inward/record.url?scp=85064934634&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/clinical-patientreported-outcome-measures-men-referred-consideration-surgery-treat-lower-urinary-tra
U2 - 10.1016/j.euf.2019.04.006
DO - 10.1016/j.euf.2019.04.006
M3 - Article
AN - SCOPUS:85064934634
VL - 5
SP - 340
EP - 350
JO - European Urology Focus
JF - European Urology Focus
SN - 2405-4569
IS - 3
ER -